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Highlights 
 Cut-off values of 38.3°C and 84 bpm allowed discrimination between 
pituitary macroadenomas and microadenomas.  
 Fifty nine per cent of dogs with pituitary macroadenomas had a body 
temperature ≤ 38.3°C. 
 Forty one per cent of dogs with pituitary macroadenomas had a heart 
rate ≤ 84 bpm. 
 Seventy five per cent of Cushing dogs with vague neurological signs 
had a heart rate ≤ 84 bpm or a body temperature ≤ 38.3°C. 
 
Abstract  
Pituitary macroadenomas compress the hypothalamus, which partly regulates heart rate and body 
temperature. The aim of this study was to investigate whether heart rate and / or body temperature 
could aid in clinically differentiating dogs with macroadenomas from dogs with microadenomas 
(i.e. small non-compressive pituitary mass). Two groups of dogs diagnosed with pituitary-
dependent hyperadrenocorticism (i.e. Cushing’s disease) were included. Heart rate and body 
temperature were collected on initial presentation before any procedure. Dogs with 
macroadenoma had a significantly lower heart rate and body temperature (p < 0.01) compared to 
dogs with microadenoma. We suggest that the combined cut-off values of 84 beats per minutes 
and 38.3°C in dogs with Cushing’s disease, especially with vague neurological signs (9 of 12 dogs 
= 75%), might help to suspect the presence of a macroadenoma.  
 
Keywords: Canine pituitary neoplasm; Cushing’s disease; Hypothermia; Bradycardia; Forebrain. 
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Pituitary-dependent hyperadrenocorticism (i.e. Cushing’s disease) in dogs can be caused by 
large (macroadenoma) or small (microadenoma) pituitary tumours. In addition to endocrine 
manifestations, macroadenomas can cause neurological signs because they expand into the 
pituitary stalk and compress and invade the hypothalamus, third ventricle and thalamus (Behrend 
2015). It is often difficult to suspect a macroadenoma because early neurological signs (such as 
lethargy, reduced appetite, delayed response to stimulation, loss of interest in household activities 
and episodes of disorientation) are non-specific and perceived as ‘ageing’ by owners. More 
definitive neurological signs eventually occur (ataxia, tetraparesis, head pressing, pacing, circling, 
etc.), probably when the brain compensatory mechanisms become overwhelmed (Nelson et al 
1989, Wood et al 2007). 
 
Previous studies reported dysfunction of the autonomic nervous system in dogs with 
macroadenomas, including impaired heart rate and body temperature regulation, which might 
result from the compression of the hypothalamus (Verstraete and Thoonen 1939, De Lahunta and 
Glass 2015). 
 
We hypothesized that dogs with macroadenomas would have lower heart rates and body 
temperature and that such findings could help differentiate macroadenomas from microadenomas 
in dogs with pituitary hyperadrenocorticism. Therefore, we compared heart rates and body 
temperatures between dogs with pituitary macroadenomas and microadenomas.  
Dogs presented to the Internal Medicine Unit, National Veterinary School of Alfort (France) 
and at the Queen’s Veterinary School Hospital, University of Cambridge (United Kingdom) were 
included between January 1st 2006 and June 30th 2011.  
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All dogs were diagnosed with hyperadrenocorticism using adrenocorticotropic hormone 
(ACTH) stimulation test, low-dose dexamethasone suppression test, ACTH plasma concentration 
measurement, serum biochemistry, hematology and adrenal glands imaging with CT or 
ultrasound. All dogs underwent brain imaging by CT or magnetic resonance imaging (MRI). We 
took advantage of the routine practice, in our institutions, to combine pituitary and adrenal CT 
scans in dogs investigated for hyperadrenocorticism. We diagnosed macroadenomas in dogs that 
had a pituitary height / brain area ratio (P/B) ≥ 0.40 x 10-2 mm-1, as previously described (Granger 
et al 2005). Conversely dogs diagnosed with microadenomas had a P/B ratio < 0.40 x 10-2 mm-1. 
 
For all dogs, attending clinicians recorded heart rate, body temperature and body weight 
within 2 weeks prior to brain imaging. In dogs presenting with obvious neurological signs, a 
neurology specialist performed the neurological examination and recorded any neurological 
deficit identified through history or physical examination. In dogs without obvious neurological 
signs, an internal medicine specialist performed the clinical examination. We did not consider 
autonomic nervous system signs (low body temperature or low heart rate) as neurological signs 
at the time of the study. The data were analysed with SAS using a p value of 0.05 to denote 
significance. Medians and interquartile ranges are reported for quantitative data. We investigated 
the association between macroadenoma and body temperature and between macroadenoma and 
heart rate by using a multivariate linear regression, including potential confounders (association 
with body temperature (or heart rate) with a p value < 0.20). The candidate variables included as 
potential confounders were: sex, age, body weight and sterilization.  We compared groups with 
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Mann-Whitney test and proportions with Fisher’s Exact Test. The association between 2 
quantitative variables was tested with Spearman’s correlation test. Finally, we examined the 
optimal threshold values for heart rate and body temperature using Receiver Operating 
Characteristic analysis. 
We recruited 59 dogs into the study: 29 in the macroadenoma group and 30 in the 
microadenoma group (Table 1). Dogs with macroadenomas had lower heart rates and lower body 
temperatures than dogs with microadenomas (P<0.05 for both comparisons; Figure 1 and 2). 
Plotting the heart rate against the body temperature resulted in more widespread dispersion of the 
plot of the macroadenoma group compared to the microadenoma group (Figure 3). 
 
The crude difference estimated by the univariate linear regression between the two groups 
(macroadenoma versus microadenoma) was estimated to be – 0.52°C (p < 0.01) and –19 bpm (p 
< 0.01) respectively for body temperature and heart rate. In both models, only the body weight 
was identified as a potential confounder. After adjustment for body weight, the temperature 
difference ∆ = – 0.65 °C and heart rate difference ∆ = – 18 bpm remained significant (p < 0.01 
and p = 0.04). 
 
The most discriminating thresholds for both parameters were determined from receiver 
operating characteristic (ROC) curves (Table 2). Using these thresholds identified with ROC (84 
bpm and 38.3°C), a greater proportion of dogs with macroadenomas had either a heart rate ≤ 84 
bpm or a body temperature ≤38.3°C or both (P<0.0002 for each comparison, Table 3).  No dogs 
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with microadenomas had both a heart rate ≤84 bpm and a body temperature ≤ 38.3°C, whereas 11 
dogs with macroadenomas exhibited both of these autonomic signs (Table 3). 
 
No dogs with microadenomas exhibited neurological deficits.  Similarly, 9/29 dogs with 
macroadenomas exhibited no neurological deficits. In the remaining 20 dogs, 12 exhibited vague 
neurological signs (i.e., only altered mentation and behavioral changes); 9 (75%) of these dogs 
had a heart rate ≤ 84 bpm or a body temperature ≤ 38.3°C, suggesting autonomic nervous system 
dysfunction. The remaining 8 dogs with macroadenomas presented with circling, cortical 
blindness and partial seizures. 
 
Our data show that the heart rate and body temperature are lower in dogs with 
macroadenomas compared to dogs with microadenomas, and that dogs with hyperadrenocorticism 
presenting with both a heart rate ≤ 84 bpm and a body temperature ≤ 38.3°C are very likely to 
have macroadenomas responsible for their endocrine disease.  However, the heart rate and the 
body temperature had a low sensitivity, i.e., a third of dogs (34%) with a macroadenomas had a 
heart rate > 84 bpm or a body temperature > 38.3°C. 
 
Diencephalic lesions can cause hypothermia or hyperthermia in humans (Carmel 1985) and 
this might occur in animals. Healthy, smaller-sized or older animals are more likely to develop 
hypothermia (Lee 2017), therefore we tested and excluded age and bodyweight as potential 
confounding factors. One possible cause for the difference in heart rate between the two groups 
is a Cushing reflex secondary to increased intracranial pressure leading to heart rate reduction 
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(Fitch et al, 1977). Another possible explanation would be a destruction of the hypothalamus by 
the macroadenoma. Concurrent measurement of the blood pressure in our study dogs would have 
helped to explore the possible causes of bradycardia, such as the Cushing’s reflex. One of the 
potential weaknesses of the study is that there is an association between HR and BW in dogs 
(Hezzel et al, 2013). Moreover, in our study, dogs with macroadenomas were larger. We included 
body weight into our modelling as a potential confounding factor, but the difference in heart rate 
remained significant after adjustment for body weight. Other limitations to this study include the 
fluctuating nature of the heart rate and body temperature and the non-standardized method of 
measurement of heart rate and body temperature.  However, we sought to reproduce the routine 
clinical situation where vital parameters are measured only once during a consultation. Therefore, 
we purposely collected data only at initial presentation. Standardized methods of measurement of 
both parameters as well as repetitive measures would require a prospective study. 
 
Because the diagnostic value of these parameters will always remain limited in dogs with 
clear forebrain neurological dysfunction, it would be of interest to evaluate the temperature and 
heart rate of dogs with macroadenomas and hyperadrenocorticism, but without obvious 
neurological signs. We had too few such dogs for meaningful comparison. 
 
In summary, our data revealed that dogs with macroadenomas had a lower heart rates and 
body temperatures than dogs with microadenomas. In the context of a case diagnosed with 
hyperadrenocorticism, the finding of a heart rate ≤ 84 bpm or a body temperature ≤ 38.3°C should 
raise the suspicion of the presence of a macroadenoma.   
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Table 1 
Signalment (body weight, age and sex) of dogs with macroadenomas and microadenomas.  
 Body weight (kg) 
 Median 
25th 
Percentile 
75th 
Percentile 
Min Max 
Macroadenoma 22.5 12.8 35 5 44 
Microadenoma 7 5 12 3 27 
 Age (years) 
 Median 
25th 
Percentile 
75th 
Percentile 
Min Max 
Macroadenoma 9 8 12 5 15 
Microadenoma 11 9 12 7 14 
 Male Female    
Macroadenoma 23 6    
Microadenoma 15 15    
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Table 2 
Results of the receiver operating characteristic curve analysis for body temperature (°C: degree 
Celsius) and heart rate (bpm: beats per minute). 
 
Area under 
the curve 
(95% CI) 
Youden 
index 
Associated 
criterion 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
Body Temperature (°C) 
0.79  
(0.66-0.88) 
0.49 ≤ 38.3 
0.62 
(0.42 – 0.79) 
0.86 
(0.69 – 0.96) 
Heart rate (bpm) 
0.70 
(0.57-0.81) 
0.38 ≤ 84 
0.41 
(0.23 – 0.61) 
0.97 
(0.83 – 0.99) 
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Table 3: Pituitary height/brain area (P/B) ratio, neurological signs, body temperature (°C: degree 
Celsius) and heart rate (bpm: beats per minute) in dogs with macroadenomas or microadenomas. 
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P/B ratio Body temperature   Heart rate Heart rate and body temperature 
 
Median Range Median Range 
Dogs with T ≤ 
38.3°C       
Number (%) 
Median Range 
Dogs with HR ≤ 
84 bpm    
Number (%) 
Dogs with T ≤ 
38.3°C or HR ≤ 
84 bpm           
Number (%) 
Dogs with T ≤ 
38.3°C and HR ≤ 
84 bpm    
Number (%) 
Macroadenoma group 
N= 29 dogs 
1 0.41-1.71 38.3 37-39.2 18 (59%) 96 52-148 12 (41%) 19 (66%) 11 (38%) 
No neurological sign 
N= 9 dogs 
0.6 0.41-1.35 38.5 37.6-39 4 (44%) 92 72-140 4 (44%) 4 (44%) 4 (44%) 
Vague neurological signs 
(altered mentation and 
behavioural changes) 
N= 12 dogs 
 
0.8 0.45-1.28 38.2 37.7-39.2 8 (67%) 93 60-120 5 (42%) 9 (75%) 4 (33%) 
Evident neurological 
signs (circling, cortical 
blindness, partial 
seizures) 
N = 8 dogs 
1 0.58-1.71 38.3 37-39.1 6 (75%) 98 52-148 3 (38%) 6 (75%) 3 (38%) 
Microadenoma group 
N= 30 dogs 
0.14 0.14-0.37 38.8 37.7-39.7 4 (13%) 108 80-180 1 (3%) 5 (17%) 0 
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Figure legends 
 
 
Figure 1: Box plot of body temperature in 29 dogs with macroadenomas and 30 dogs with 
microadenomas. The box represents interquartile range (25th to 75th percentile). The bars represent 
the minimum and maximum data values. Median values are indicated by horizontal lines.  
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Figure 2: Box plot of heart rate in 29 dogs with macroadenomas and 30 dogs with 
microadenomas. See Figure 1 for legend. 
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Figure 3: Plot of the heart rate (x-axis) against the body temperature (y-axis) for dogs with 
macroadenoma (solid circle) and dogs with microadenomas (open circle). Dogs in the 
microadenoma group are mainly located in the upper right quadrant. Note the dispersion of the 
data in the macroadenoma group towards the left with 12 dogs with a HR ≤ 84 bpm and 18 dogs 
with a BT ≤ 38.3°C but only one dog in the microadenoma group with a HR ≤ 84 bpm and 4 with 
a BT ≤ 38.3°C. Dashed lines on both plots represent the cut off value found using ROC curves 
for heart rate and body temperature. 
